5
Views
1
CrossRef citations to date
0
Altmetric
Review

Treatment of acne: an update

&
Pages 429-438 | Published online: 10 Jan 2014

References

  • Burton JL, Cunliffe WJ, Stafford L et al. The prevalence of acne vulgaris in adolescence. Br. J. Dermatol.85, 119–126 (1971).
  • Iurassich S, Trotta C, Palagiano A, Pace L. Correlations between acne and polycystic ovary. A study of 60 cases. Minerva Ginecol.53, 107–111 (2001).
  • Thiboutot D, Gilliland K, Light J et al. Androgen metabolism in sebaceous glands from subjects with and without acne. Arch. Dermatol.135, 1041–1045 (1999).
  • Layton AM. A review on the treatment of acne vulgaris. Int. J. Clin. Pract.60(1), 64–72 (2006)
  • Jeremy AH, Holland DB, Roberts SG et al. Inflammatory events are involved in acne lesion initiation. J. Invest. Dermatol.121, 20–27 (2003).
  • Guy R, Kealey T. The effects of inflammatory cytokines on the isolated human sebaceous infundibulum. J. Invest. Dermatol.110, 410–415 (1998).
  • Layton AM, Henderson CA, Cunliffe WJ. A clinical evaluation of acne scarring and its incidence. Clin. Exp. Dermatol.19, 303–308 (1994).
  • Cunliffe WJ, Gollnick H. Acne: Diagnosis and Management. Martin Dunitz Ltd, London (2001).
  • Cook CH, Centner RL, Michaels SE. An acne grading method using photographic standards. Arch. Dermatol.115, 571–575 (1979).
  • Pillsbury DM, Shelley WB, Kligman AM. A Manual of Cutaneous Medicine. Saunders, Philadelphia, USA (1961).
  • Lasek RJ, Chren MM. Acne vulgaris and the quality of life of adult dermatology patients. Arch. Dermatol.134, 454–458 (1998).
  • Rubinov DR. Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin. J. Am. Acad. Dermatol.17(1), 25–32 (1987).
  • Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br. J. Dermatol.139, 846–850 (1998).
  • Jowett S, Ryan T. Skin disease and handicap: an analysis of the impact of skin conditions. Soc. Sci. Med.20, 425–429 (1985).
  • Finlay AY, Khan GK. Dermatology Life Quality Index (OLQI). A simple practical measure for routine clinical use. Clin. Exp. Dermatol.19, 210–216 (1994).
  • Motley RJ, Finlay AY. Practical use of a disability index in the routine management of acne. Clin. Exp. Dermatol.17, 1–3 (1992).
  • Layton AM, Seukeran DC, Cunliffe WJ. Scarred for life. Dermatology195, 15–21 (1997).
  • Ozolins M, Eady EA, Avery A. Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial. Lancet364, 2188–2195 (2004).
  • Christophers E, Wolfe HH. Effect of vitamin A acid on skin: in vivo and in vitro studies. Acta Derm. Venereol. (Stockh.)74, 42–53 (1975).
  • Leyden J. Rational therapy for acne vulgaris: an update on topical treatment. J. Am. Acad. Dermatol.15, 970–915 (1986).
  • Gollnick MD, Cunliffe W et al. Management of acne. A report from a global alliance to improve outcomes in acne. J. Am. Acad. Dermatol.49, S1–S3 (2003).
  • Shalita AR, Weiss JS, Chalker DK et al. A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: a multicentre trial. J. Am. Acad. Dermatol.34, 482–485 (1999).
  • Schefer H. Penetration and percutaneous absorption of topical retinoids. A review. Skin Pharmacol.6, 17–23 (1993).
  • Fulton JE, Farzad-Batshandeth A. Studies on the mechanism of action of topical benzoyl peroxide in acne vulgaris. J. Cutan. Path.1, 191–200 (1974).
  • Eady EA, Farmery MR, Ross JI et al. Effects of benzoyl peroxide and erythromycin alone and in combination against antibiotic sensitive and resistant skin bacteria from acne patients. Br. J. Dermatol.131, 331–336 (1994).
  • Holland KT, Bojar RA. Antimicrobial effects of azelaic acid. J. Dermatol. Treat.4, S8–S11 (1993).
  • Mayer De Dilva A, Gollnick H, Detmar M et al. Effects of azelaic acid on sebaceous glands, sebum excretion rate and keratinisation patterns in human skin. Acta Derm. Venereol.143, 20–30 (1979).
  • Eady EA, Hope JH, Jones DN et al. Topical antibiotics for the treatment of acne: a critical evaluation of the literature on their clinical benefit and comparative efficacy. J. Dermatol. Treat.1, 215–226 (1990).
  • Thomas DR, Raimer S, Smith BE. Comparison of topical erythromycin 1.5% solution vs topical clindamycin phosphate 1% solution in the treatment of acne vulgaris. Cutis29, 624–532 (1982).
  • Eady EA, Jones CE and Tipper JL et al. Antibiotic resistant propionibacteria in acne. Need for policy for antibiotic usage. Br. Med. J.306, 555–556 (1993).
  • Fenchi CL, Allen BS, Chalker DK et al. Topical erythromycin with zinc in acne. A double blind controlled study. J. Am. Acad. Dermatol.3, 483–491 (1980).
  • Chalker DK, Shalita AR, Smith JG et al. A double blind study of the effectiveness of a 3% erythromycin and 5% benzoyl peroxide combination in the treatment of acne vulgaris. J. Am. Acad. Dermatol.9, 933–936 (1983).
  • Farmery MR, Jones CE, Eady CA et al. In vitro activity of azelaic acid, benzoyl peroxide and zinc acetate against antibiotic resistant propionibacteria from acne patients. J. Dermatol. Treat.5, 63–65 (1994).
  • Tucker SB, Tousend R, Cochrane R et al. Comparison of topical clindamycin phosphate, benzoyl peroxide and a combination of the two in the treatment of acne vulgaris. Br. J. Dermatol.1001, 487–492 (1984).
  • Rietschel R, Duncan BS. Clindamycin phosphate used in combination with tretinoin in the treatment of acne. Int. J. Dermatol.22, 41–43 (1983).
  • Mills OH, Kligman AM. Treatment of acne vulgaris with topically applied erythromycin and tretinoin. Acta Derm. Venereol. (Stockh.)58, 555–557 (1978).
  • Marples RR, Kligman AM. Ecological effects of oral antibiotics on the microflora of human skin. Arch. Dermatol.103, 143–153 (1971).
  • Esterley NB, Furcy NL and Fiaragcan LE. The effect of antimicrobial agents on leukocyte chemotaxis. J. Invest. Dermatol.70, 51–55 (1979).
  • Dreno B, Bettoli V, Ochsendorf F et al. European recommendations on the use of oral antibiotics for acne. Eur. J. Dermatol.14, 391–9 (2004).
  • Cunliffe WJ, Cleydon AD, Gould D et al. Acne vulgaris – its aetiology and treatment. A review. Clin. Exp. Dermatol.6,461–469 (1981).
  • DeRossi SS, Hersh EV. Antibiotics and oral contraceptives. Dent. Clin. N. Am.46(4), 653–654 (2002).
  • Knaggs HE, Layton AM, Cunliffe WJ. The role of oral minocycline and erythromycin in tetracycline resistant acne – a retrospective study and a review. J. Dermatol. Treat.4, 53–56 (1993).
  • Garner SE, Eady EA, Propescu C et al. Minocycline for acne vulgaris: efficacy and safety. Cochrane Database Syst. Rev.1, CD002086 (2003).
  • Eady EA, Cove JH, Holland KT, Cunliffe WJ. Erythromycin resistant propionibacteria in antibiotic treated acne patients associated with therapeutic failure. Br. J. Dermatol.121(1), 51–57 (1989).
  • Bottomley WW, Cunliffe WJ. Oral trimethoprim as a third line antibiotic treatment in the management of acne vulgaris. Dermatology187, 193–196 (1993).
  • Eady EA, Gloor M, Lleyden JJ. Propionibacterium acnes resistance: a worldwide problem. Dermatology206, 54–56 (2003).
  • Eady EA, Jones CE, Gardner KJ et al. Tetracycline resistant propionibacteria from acne patients are cross-resistant to doxycycline but sensitive to minocycline. Br. J. Dermatol.128, 556–560 (1993).
  • Ozolins M, Eady EA, Avery A, Cunliffe WJ et al. Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial. Lancet364, 2188–2195 (2004).
  • Coates P, Adams CA, Cunliffe WJ et al. Does oral isotretinoin prevent propionibacteria acnes resistance? Dermatology195(Suppl. 1), 4–9 (1997).
  • Coates P, Vyakrnam S, Ravenscrof JC et al. Efficacy of oral isotretinoin in the control of skin and nasal colonisation by antibiotic resistant propionibacteria. Br. J. Dermatol.153(6), 1126–1136 (2005).
  • Thiboutot D. Hormones and acne: pathophysiology, clinical evaluation, and therapies. Sem. Cutan. Med. Surg.20, 144–153 (2001).
  • Huber J, Foidart JM, Wuttke W et al. Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone. Eur. J. Contracept. Reprod. Health Care5, 25–34 (2000).
  • Hanstead B, Reymann F. Cyproterone acetate in the treatment of acne vulgaris in adult females. Dermatologica164, 117–126 (1982).
  • Greenwood R, Brummitt L and Burke B et al. Acne: a double blind clinical and laboratory trial of tetracycline, oestrogen, cyproterone acetate and combined treatment. Br. Med. J.291, 1231–1235 (1985).
  • Aurowojolu AO, Gallo MF, Grimes DA, Garner SE. Combined oral contraceptive pills for the treatment of acne. Cochrane Database Syst. Rev.3, CD004425 (2004).
  • Burke BM, Cunliffe WJ. Oral spironolactone therapy for female patients with acne, hirsutism or androgenic alopecia. Br. J. Dermatol.112(1), 124–126 (1984).
  • Cunliffe WJ. Treatment of acne. In: Acne and Acne Related Disorders. Marks R (Ed.). Martin Dunitz Publishers, London, 266–276 (1993).
  • Layton AM, Knaggs HE, Taylor J et al. Isotretinoin for acne vulgaris – 10 years later. A safe and successful treatment. Br. J. Dermatol.129, 292–296 (1993).
  • Cunliffe WJ, Van De Kerkhof PCM, Caputo R et al. Roaccutane treatment guidelines, results of an international survey. Dermatology194, 351–357 (1997).
  • Clark SM, Cunliffe WJ. Acne flare and isotretinoin – incidence and treatment. Br. J. Dermatol.133, 26 (1995).
  • Pepall LM, Cosgrove MP, Cunliffe WJ. Ablation of whiteheads by cautery under topical anaesthetic. Br. J. Dermatol.125, 256–259 (1991).
  • Karvone S. Acne fulminans: report of clinical findings and treatment of 24 patients. J. Am. Acad. Dermatol.28, 572–579 (1993).
  • Jacobs DG, Deutsch NL, Brewer M. Suicide, depression and isotretinoin. Is there a causal link. J. Am. Acad. Dermatol.45, S168–S175 (2001).
  • Marqueling AL, Zane LT. Depression and suicidal behaviour in acne patients treated with isotretinoin: a systematic review. Semin. Cutan. Med. Surg.24, 92–102 (2005).
  • Atzori L, Brundu MA, Orru A. Glycolic acid peeling in the treatment of acne. J. Euro. Acad. Dermatol. Venereol.12, 119–122 (1999).
  • Acne. Orentreich N, Durr NP, Frank SB (Ed.). Yorke medical books, NY, USA (1979).
  • Charakida A, Seaton ED, Charakida M. Phototherapy in the treatment of acne – what is its role? Am. J. Clin. Dermatol.5(4), 211–216 (2004).
  • Pollock B, Turner D, Stringer MR. Topical aminolaevulinic acid-photodynamic therapy for the treatment of acne vulgaris: a study of clinical efficacy and mechanism of action Br. J. Dermatol.151, 616–622 (2004).
  • Papageorgiou P, Katsambar A, Chu A. Phototherapy with blue (415 nm) and red (600 nm) light in the treatment of acne vulgaris. Br. J. Dermatol.142(5), 973–978 (2000).
  • Sneddon J, Sneddon I. Acne excoriée: a protective device. Clin. Exp. Dermatol.8, 65–68 (1983).
  • Kent A, Drummond LM. Acne excoriée – a case report using habit reversal. Clin. Exp. Dermatol.14, 163–164 (1989).
  • Cotterill JA. Dermatological non-disease. Dermatol. Clin.14, 439–445 (1996).
  • Kligman AM, Mills OH. Acne cosmetica. Arch. Dermatol.111, 65–68 (1975).
  • Khanna N, Gupta S. Acneiform eruptions after facial beauty treatment. Int. J. Dermatol.38, 196–199 (1999).
  • Cunliffe WJ. Clinical features of acne. In Acne. Marks R (Ed.). Martin Dunitz Publishers, London, 59 (1989).
  • Plewig G, Fulton JE, Kligman AM. Pomade acne. Arch. Dermatol.101, 580 (1970).
  • Goulden V, Stables GI, Cunliffe WJ. The prevalence of facial acne in adults. J. Am. Acad. Derm.41, 577–580 (1999).
  • Goulden V, Clark SM, Cunliffe WJ. Post adolescent acne a review of clinical features. Br. J. Dermatol.136, 66–70 (1997).
  • Cunliffe WJ. Management of adult acne and acne variants. J. Cut. Med. Surg.2, S3–S7 (1998).
  • Khanna N, Gupta S. Acneiform eruptions after facial beauty treatment. Int. J. Dermatol.38, 196–199 (1999).
  • Leyden JJ, Marples RR, Mills OK. Gram negative folliculitis – a complication of antibiotic therapy in acne vulgaris. Br. J. Dermatol.88, 533–538 (1973).
  • James WD, Leyden JJ. Treatment of gram negative folliculitis with isotretinoin. Positive clinical and microbiological response. J. Am. Acad. Dermatol.12, 319–324 (1985).
  • Karvone SL, Rasane L, Cunliffe WJ et al. Delayed hypersensitivity to propionibacteria acnes in patients with severe nodular acne and acne fulminans. Dermatology189, 344–349 (1994).
  • Massa MC, Su WP. Pyoderma faciale: a clinical study of twenty-nine patients. J. Am. Acad. Dermatol.6, 84–91 (1982).
  • Layton AM. Early detection and intervention in adolescent acne. Presented at World Congress of Paediatric Dermatology (2004).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.